Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock Price
Structure Therapeutics Inc. American Depositary Shares Price
The consensus 12-month price target for Structure Therapeutics Inc. American Depositary Shares is 111.00 USD, about 208.9% above where the stock trades today. Of 23 analysts, 21 rate the stock a buy — an overall Buy consensus. The stock trades about 44% above its 52-week low.
Structure Therapeutics Inc. American Depositary Shares stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Structure Therapeutics Inc. American Depositary Shares over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Structure Therapeutics Inc. American Depositary Shares stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Structure Therapeutics Inc. American Depositary Shares's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Structure Therapeutics Inc. American Depositary Shares Price |
|---|---|
| 9/25/2026 | 35.93 USD |
| 9/24/2026 | 36.02 USD |
| 9/23/2026 | 35.95 USD |
| 9/22/2026 | 36.82 USD |
| 9/21/2026 | 35.86 USD |
| 9/18/2026 | 34.64 USD |
| 9/17/2026 | 35.10 USD |
| 9/16/2026 | 37.15 USD |
| 9/15/2026 | 38.26 USD |
| 9/14/2026 | 38.44 USD |
| 9/11/2026 | 38.89 USD |
| 9/10/2026 | 39.55 USD |
| 9/9/2026 | 41.23 USD |
| 9/8/2026 | 43.60 USD |
| 9/4/2026 | 47.34 USD |
| 9/3/2026 | 47.34 USD |
| 9/2/2026 | 47.80 USD |
| 9/1/2026 | 47.13 USD |
| 8/31/2026 | 45.91 USD |
| 8/28/2026 | 47.35 USD |
| 8/27/2026 | 49.50 USD |
| 8/26/2026 | 49.35 USD |
| 8/25/2026 | 49.92 USD |
| 8/24/2026 | 47.85 USD |
| 8/21/2026 | 49.09 USD |
| 8/20/2026 | 50.52 USD |
| 8/19/2026 | 52.66 USD |
| 8/18/2026 | 53.38 USD |
| 8/14/2026 | 54.51 USD |
| 8/13/2026 | 54.70 USD |
Structure Therapeutics Inc. American Depositary Shares Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Structure Therapeutics Inc. American Depositary Shares Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 38.00 | – | 187.00 | 539.00 | 970.00 |
| – | – | – | – | – | – | – | – | – | 188.24 | 79.96 |
| – | – | – | – | – | – | -7.89 | – | -1.60 | -0.56 | -0.31 |
| -3.00 | -3.00 | -3.00 | -3.00 | -2.00 | -3.00 | -3.00 | -3.00 | -3.00 | -3.00 | -3.00 |
| – | -37.00 | -52.00 | -102.00 | -158.00 | -287.00 | -89.00 | -121.00 | -43.00 | 1.00 | 141.00 |
| – | – | – | – | – | – | -234.21 | – | -22.99 | 0.19 | 14.54 |
| – | -40.00 | -51.00 | -89.00 | -122.00 | -141.00 | -118.00 | -152.00 | -125.00 | -3.00 | 130.00 |
| – | – | 27.50 | 74.51 | 37.08 | 15.57 | -16.31 | 28.81 | -17.76 | -97.60 | -4,433.33 |
| 36.59 | 36.59 | 36.59 | 46.41 | 57.29 | 59.20 | 59.20 | 59.20 | 59.20 | 59.20 | 59.20 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Structure Therapeutics Inc. American Depositary Shares generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Structure Therapeutics Inc. American Depositary Shares retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Structure Therapeutics Inc. American Depositary Shares's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Structure Therapeutics Inc. American Depositary Shares has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Structure Therapeutics Inc. American Depositary Shares's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Structure Therapeutics Inc. American Depositary Shares stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Structure Therapeutics Inc. American Depositary Shares Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Structure Therapeutics Inc. American Depositary Shares business model & stock analysis
Structure Therapeutics Inc. American Depositary Shares Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Structure Therapeutics Inc. American Depositary Shares Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Structure Therapeutics Inc. American Depositary Shares historical P/E ratio, EBIT multiple, and P/S ratio
Structure Therapeutics Inc. American Depositary Shares annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Structure Therapeutics Inc. American Depositary Shares's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Structure Therapeutics Inc. American Depositary Shares's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Structure Therapeutics Inc. American Depositary Shares's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Structure Therapeutics Inc. American Depositary Shares shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Structure Therapeutics Inc. American Depositary Shares forecasts and price targets in September 2026
Analyst Price Targets 2026Structure Therapeutics Inc. American Depositary Shares Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/7/2026 | Maintained | Market Outperform | – | |
| 8/7/2026 | Maintained | Buy | 46 | |
| 6/11/2026 | Maintained | Buy | – | |
| 3/16/2026 | Maintained | Buy | – | |
| 3/2/2026 | Maintained | Buy | – | |
| 2/27/2026 | Maintained | Market Outperform | – | |
| 1/22/2026 | Maintained | Overweight | 53 | |
| 1/20/2026 | Maintained | Buy | 39 | |
| 12/19/2025 | Maintained | Buy | – | |
| 12/12/2025 | Maintained | Overweight | 46 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Structure Therapeutics Inc. American Depositary Shares Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 11/5/2026 | -0.33USD | - | 50.00 MUSD | - | 2026 Q3 |
| 8/6/2026 | -0.39USD | -0.49USD | -USD | - | 2026 Q2 |
| 5/7/2026 | -0.39USD | -0.35USD | 11.11 MUSD | - | 2026 Q1 |
| 2/26/2026 | -0.35USD | -0.49USD | 9.19 MUSD | - | 2025 Q4 |
| 11/6/2025 | -0.36USD | -0.37USD | -USD | - | 2025 Q3 |
| 8/6/2025 | -0.28USD | -0.36USD | -USD | - | 2025 Q2 |
| 2/27/2025 | -0.23USD | -0.22USD | -USD | - | 2024 Q4 |
| 11/13/2024 | -0.19USD | -0.20USD | -USD | - | 2024 Q3 |
| 8/8/2024 | -0.23USD | -0.18USD | -USD | - | 2024 Q2 |
| 5/9/2024 | -0.21USD | -0.19USD | -USD | - | 2024 Q1 |
Structure Therapeutics Inc. American Depositary Shares shareholder structure
| % | Name |
|---|---|
11.82344% | |
10.21504% | |
9.22350% | |
7.53432% | |
6.02164% | |
4.86723% |
Structure Therapeutics Inc. American Depositary Shares Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
15.00% | SEC ↗ | |
10.10% | SEC ↗ | |
9.38% | SEC ↗ | |
7.70% | SEC ↗ | |
7.61% | SEC ↗ | |
7.61% | SEC ↗ | |
6.90% | SEC ↗ | |
6.20% | SEC ↗ | |
5.95% | SEC ↗ | |
5.20% | SEC ↗ |
Frequently asked questions about Structure Therapeutics Inc. American Depositary Shares
Analysts currently set an average price target of 108.67 USD for the Structure Therapeutics Inc. American Depositary Shares stock (median: 111.00 USD), implying +201.7 % versus the latest price. The consensus is based on 23 analyst ratings.
Structure Therapeutics Inc. American Depositary Shares Analyst Price Targets 2026
23 analysts currently rate the Structure Therapeutics Inc. American Depositary Shares stock: 21 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Structure Therapeutics Inc. American Depositary Shares to generate revenue of 38.46 M USD and earnings per share of -2.00 USD.
Structure Therapeutics Inc. American Depositary Shares Analyst Price Targets 2026
Converted at the current exchange rate, the Structure Therapeutics Inc. American Depositary Shares share trades at 31.52 EUR (35.93 USD).
No history available for Structure Therapeutics Inc. American Depositary Shares.
The expected revenue of Structure Therapeutics Inc. American Depositary Shares is 38.46 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Structure Therapeutics Inc. American Depositary Shares is -118.38 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Structure Therapeutics Inc. American Depositary Shares is currently -17.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Structure Therapeutics Inc. American Depositary Shares stock.
The price-to-sales ratio (P/S) of Structure Therapeutics Inc. American Depositary Shares is currently 55.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Structure Therapeutics Inc. American Depositary Shares stock.
The Eulerpool Quality Score for Structure Therapeutics Inc. American Depositary Shares is 2/10.
The ISIN of Structure Therapeutics Inc. American Depositary Shares is US86366E1064. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Structure Therapeutics Inc. American Depositary Shares is GPCR. The ticker symbol is used to trade Structure Therapeutics Inc. American Depositary Shares shares on the stock exchange.
Structure Therapeutics Inc. American Depositary Shares paid dividends every year for the past 0 years.
Structure Therapeutics Inc. American Depositary Shares is assigned to the 'Health' sector.
The dividends of Structure Therapeutics Inc. American Depositary Shares are distributed in USD.
Structure Therapeutics Inc. American Depositary Shares stock
Structure Therapeutics Inc. American Depositary Shares Peer Group
All fundamentals and in-depth analysis of Structure Therapeutics Inc. American Depositary Shares
Our stock analysis for Structure Therapeutics Inc. American Depositary Shares stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Structure Therapeutics Inc. American Depositary Shares. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.